Navigation Links
AbbVie Reports Third-Quarter 2013 Financial Results
Date:10/25/2013

5)

n/a

n/a

(69.5)

(69.5)Duodopa

--

129

129

n/a

16.6

19.4

16.6

19.4Note: "Operational" growth reflects the percentage change over the prior year excluding the impact of exchange rate fluctuations.
n/a = not applicable  AbbVie Inc.
Consolidated Statements of Earnings
Quarter and Nine Months Ended September 30, 2013 and 2012
(Unaudited) (In millions, except per share data)Third Quarter Ended September 30Nine Months Ended
September 302013201220132012Net sales

$4,658$4,508$13,679$13,174Cost of products sold

1,0921,0143,2993,243Selling, general and administrative

1,2611,0853,9043,578Research and development

7148132,0572,097Acquired in-process research and development

220--290260Total operating cost and expenses

3,2872,9129,5509,178Operating earnings

1,3711,5964,1293,996Interest (income) expense, net

69(1)210(4)Net foreign exchange (gain) loss

1164027Other (income) expense, net

5(13)(14)(39)Earnings before income tax

1,2861,6043,8934,012Income tax expense

32219893277Net earnings

$964$1,585$3,000$3,735Diluted earnings per share

$0.60$1.01$1.86$2.37Average diluted shares outstanding1,6051,5771,6021,577Note: On Jan. 1, 2013, Abbott Laboratories distributed 1,577 million shares of AbbVie common stock to Abbott's shareholders in connection with the separation of AbbVie from Abbott. The computation of diluted earnings per share for the quarter and nine months ended Sept. 30, 2012 was calculated using the shares distributed on Jan. 1, 2013. AbbVie Inc.
Reconciliation of GAAP Reported to Non-GAAP Adjusted Information
Quarter Ended September 30, 2013
(Unaudited) (In millions, except per share data)1. Specified items impacted results as follows:3Q13Earnings

DilutedPre-tax

After-tax

EPSAs
'/>"/>

SOURCE AbbVie
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. AbbVie Named a Science Top Employer
2. AbbVie To Present Investigational Data From Phase II Hepatitis C Program At The Liver Meeting
3. AbbVie and Galapagos to Co-Develop Cystic Fibrosis Therapies
4. Strong Sales and Healthcare Reforms Benefit Earnings - Research Report on Gilead, Pfizer, Merck, AbbVie, and LifePoint
5. After Reviewing Brief Product Profiles, Surveyed Physicians Believe that Likely Candidates for Late-Phase Chronic Kidney Disease Products from AbbVie, Mitsubishi Tanabe, Eli Lilly, Concert, Fibrogen and Pfizer are Typically Stage 3b and 4 Patients
6. AbbVie Declares Quarterly Dividend
7. AbbVie Presents Preliminary Results from Phase I Study of Investigational Oncology Compound ABT-199/GDC-0199 in Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) at European Hematology Association Annual Meeting
8. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
9. AbbVie to Participate in 2013 Jeffries Global Healthcare Conference
10. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
11. AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohns Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015 Research ... the addition of the "Arthroscopy Devices ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of ... the world market for Arthroscopy Devices. The ... impacting the market for these products. , ...
(Date:5/21/2015)... May 21, 2015  (MUSE Booth # 1510)What:Automating ... Record (EHR) is invaluable in any hospital setting, ... now a requirement and mainstream in healthcare, the ... the EHR is gaining traction in MEDITECH facilities.During ... RN, Site Project Manager & Clinical Analyst at ...
(Date:5/21/2015)... 21, 2015 ... Zwecks Leistungsvergleich zur Expertise und zum ... verwiesen, in denen uneingeschränkt betriebsfähige Systeme, ... ein Aegate-Land: beispielsweise BELGIEN   ... von Arzneimittelfälschungen (FMD) handelt es sich ...
Breaking Medicine Technology:Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 2EU-Arzneimittel-Richtlinie für gefälschte Medikamente; Aegate-Zusammenfassung als reale Bewertung aus Belgien 3
... July 25, 2011 Reportlinker.com ... research report is available in ... Global Medical Devices Industry Outlook ... Trends and Opportunities, Marketing Spend ...
... Valeant Pharmaceuticals International, Inc. (NYSE: ... wholly owned subsidiary, Valeant Canada Limited, has received ... has been approved from the Canadian regulatory authority ... the short-term treatment and symptomatic relief of insomnia ...
Cached Medicine Technology:Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 2Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 3Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 4Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 5Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 6Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 7Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 8Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 9Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies 10Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada 2Valeant Pharmaceuticals Announces Approval of Sublinox® in Canada 3
(Date:5/24/2015)... Michigan (PRWEB) May 24, 2015 ... them to take pressure measurements in patients’ bladder and ... doctor usually orders it if they have reported symptoms ... , Women’s Excellence in Bladder Control is ... unwanted urinary leakage or problems with overall control of ...
(Date:5/24/2015)... ProPin is a set of self-animating ... Utilize ProPin to pin point locations on a map, to ... , ProPin allows users to choose from 30 simplistic presets with ... on-screen controls, video editors can easily manipulate ProPin presets as a ... with absolute ease. , Using ProPin is easy, simply drag a ...
(Date:5/24/2015)... A report out just last month ... option for avoiding cardiovascular disease is exercise and maintaining ... single most powerful predictor of death and survival, even ... family history of premature death -- a finding that ... fitness. , The Importance of Cardiovascular Screening , The ...
(Date:5/23/2015)... With the implementation of the Affordable Care ... difficult to provide their employees with a viable healthcare ... for employees stand to face strict penalties. Never before ... of a business’s success or failure. In an effort ... Doctors has created a varying level of less expensive ...
(Date:5/23/2015)... IL (PRWEB) May 23, 2015 A live ... medical equipment from hospitals, surgery centers and other medical facilities ... be sold including endoscopy, lab, radiology, surgery, anesthesia, exam and ... Wednesday, May 27 and Thursday, May 28 starting at 9:00am ... located at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
Breaking Medicine News(10 mins):Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2
... ... the bimonthly biomedical journal, Molecular Medicine. Molecular Medicine publishes research concerned with the pathogenesis ... disease diagnosis, treatment and prevention. , ... (Vocus) January 12, 2010 -- By the time a person experiences ...
... NASHVILLE, Tenn. , Jan. 12 Emdeon Inc. (NYSE: ... management solutions, today announced that it will make a presentation to attendees ... January 25 to 27, 2010 , in New York . ... at 11:45 a.m. Eastern time on Tuesday, January 26, ...
... for women, exercise cuts that risk significantly, study finds , ... 70, every 10-beat-per-minute increase in resting heart rate boosts the ... a new study has found. , Norwegian researchers tracked the ... for an average of 18 years. During that time, 6,033 ...
... ... 15 countries participate in SharpBrains Summit without taking a single flight , ... San Francisco, ... on brain fitness, today announced the inaugural SharpBrains Summit, the first global and ...
... WASHINGTON , Jan. 12 The American Lung ... report, which grades the strength of federal and state ... at the heart of America,s chronic disease crisis. , The ... still has significant room for progress. Most state governments , ...
... ... On-the-Ground Expertise ,to Support MediSend’s Work in Developing Countries , ... Trevose, PA (PRWEB) ... international healthcare, security services and outsourced customer care, has signed a memorandum of ...
Cached Medicine News:Health News:News from the Latest Issue of Molecular Medicine 2Health News:Emdeon to Present at the Jefferies Global Healthcare Services Conference 2Health News:Faster Heart Rate May Raise Risk of Heart Attack Death 2Health News:First Global, Virtual Summit on Cognitive Health and Performance Features 200 Sharp Brains 2Health News:First Global, Virtual Summit on Cognitive Health and Performance Features 200 Sharp Brains 3Health News:First Global, Virtual Summit on Cognitive Health and Performance Features 200 Sharp Brains 4Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 2Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 4Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 5Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 6Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 7Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 8Health News:International SOS and MediSend to Partner on Humanitarian Healthcare 2Health News:International SOS and MediSend to Partner on Humanitarian Healthcare 3
... Designed To Safely And Easily Cut ... Incision.,Specially Designed To Cut And Remove ... Ease With One Instrument.,New Miniaturized Profile ... Incision For Explantation Of A Silicone ...
... As One Unit, Shaped Like A Fan, And ... A Phaco Incision. The Gauges Start At A ... To With 100-Micron Increments. The Gauges ... As To The Preoperative And Postoperative Incision Result. ...
... Speculums Designed To Rest Either Nasally ... Speculums Over, Allowing Eyelids To Be ... The Widest Possible Aperture.,Open And Close ... Access To The Globe During Clear ...
... Handle, Designed To Dial An Exact Extension ... Allows Maximum Visibility, With Titanium Handle & ... Better In Tissue, And Can Also Be ... Paracentesis., ,Reusable, Autoclaveable, Made In The USA, Handle ...
Medicine Products: